GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,006,000 | -47.0% | 42,087 | -67.6% | 0.00% | -33.3% |
| Q4 2020 | $1,897,000 | +7.1% | 129,929 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $1,772,000 | +104.6% | 124,817 | +111.9% | 0.00% | +200.0% |
| Q2 2020 | $866,000 | +314.4% | 58,897 | +35.6% | 0.00% | – |
| Q4 2019 | $209,000 | -72.6% | 43,420 | -65.5% | 0.00% | -100.0% |
| Q3 2019 | $763,000 | +178.5% | 125,866 | +198.2% | 0.00% | – |
| Q2 2019 | $274,000 | +226.2% | 42,210 | +257.5% | 0.00% | – |
| Q1 2019 | $84,000 | -62.3% | 11,807 | -49.1% | 0.00% | – |
| Q3 2017 | $223,000 | -52.7% | 23,204 | -41.8% | 0.00% | -100.0% |
| Q2 2017 | $471,000 | +10.3% | 39,853 | +19.6% | 0.00% | 0.0% |
| Q1 2017 | $427,000 | +125.9% | 33,319 | +116.1% | 0.00% | – |
| Q4 2016 | $189,000 | +75.0% | 15,418 | +27.5% | 0.00% | – |
| Q3 2014 | $108,000 | -31.6% | 12,094 | +3.4% | 0.00% | – |
| Q2 2014 | $158,000 | -22.9% | 11,694 | -43.2% | 0.00% | -100.0% |
| Q1 2014 | $205,000 | -34.1% | 20,594 | -12.0% | 0.00% | 0.0% |
| Q4 2013 | $311,000 | +9.5% | 23,394 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $284,000 | – | 23,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |